The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a
Open accessAbstract
The Angelman syndrome gene, UBE3A, is subject to genomic imprinting controlled by mechanisms that are only partially understood. Its antisense transcript, UBE3A-ATS, is also imprinted and hypothesized to suppress UBE3A in cis. In this research, we showed that the mouse antisense ortholog, Ube3a-ATS, was transcribed by RNA polymerase (RNAP) II. However, unlike typical protein-coding transcripts, Ube3a-ATS was not poly-adenylated and was localized exclusively in the nucleus. It was relatively unstable with a half-life of 4 h, shorter than most protein-coding RNAs tested. To understand the role of Ube3a-ATS in vivo, a mouse model with a 0.9-kb genomic deletion over the paternal Snrpn major promoter was studied. The mice showed partial activation of paternal Ube3a, with decreased expression of Ube3a-ATS but not any imprinting defects in the Prader-Willi syndrome/Angelman syndrome region. A novel cell culture model was also generated with a transcriptional termination cassette inserted downstream of Ube3a on the paternal chromosome to reduce Ube3a-ATS transcription. In neuronally differentiated embryonic stem (ES) cells, paternal Ube3a was found to be expressed at a high level, comparable with that of the maternal allele. To further characterize the antisense RNA, a strand-specific microarray was performed. Ube3a-ATS was detectable across the entire locus of Ube3a and extended beyond the transcriptional start site of Ube3a. In summary, we conclude that Ube3a-ATS is an atypical RNAPII transcript that represses Ube3a on the paternal chromosome. These results suggest that the repression of human UBE3A-ATS may activate the expression of UBE3A from the paternal chromosome, providing a potential therapeutic strategy for patients with Angelman syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, paternal-specific deletion of multiple imprinted, paternally expressed genes on the 15q11–q13 region results in Prader–Willi syndrome, whereas maternal deletion of a single, imprinted, maternally expressed gene encoding a ubiquitin-protein ligase (UBE3A) on this same region gives rise to the Angelman syndrome phenotype.”
From Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms (2014) · cites this paper as [195]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pandey, R. R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., Komorowski, J., Nagano, T., Mancini‐DiNardo, D., & Kanduri, C. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.022 · Cited by 1,192
The non-coding Air RNA is required for silencing autosomal imprinted genes
Sleutels, F., Zwart, R., & Barlow, D. P. (2002) · Nature · doi:10.1038/415810a · Cited by 1,096
A long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expression
Bernard, D., Prasanth, K. V., Tripathi, V., Colasse, S., Nakamura, T., Xuan, Z., Zhang, M. Q., Sedel, F., Jourdren, L., Coulpier, F., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.199 · Cited by 749
Differentiation of mouse embryonic stem cells into a defined neuronal lineage
Bibel, M., Richter, J., Schrenk, K., Tucker, K. L., Staiger, V., Korte, M., Goetz, M., & Barde, Y.-A. (2004) · Nature Neuroscience · doi:10.1038/nn1301 · Cited by 450
Mechanisms regulating imprinted genes in clusters
Edwards, C. A., & Ferguson‐Smith, A. C. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.04.013 · Cited by 422
Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genesPreprint
Mancini‐DiNardo, D., Steele, S. J., Levorse, J. M., Ingram, R. S., & Tilghman, S. M. (2006) · Genes & Development · doi:10.1101/gad.1416906 · Cited by 421
Dindot, S. V., Antalffy, B. A., Bhattacharjee, M. B., & Beaudet, A. L. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm288 · Cited by 418
Self-citationThe Angelman syndrome candidate gene, UBE3AIE6-AP, is imprinted in brain
Rougeulle, C., Glatt, H., & Lalande, M. (1997) · Nature Genetics · doi:10.1038/ng0997-14 · Cited by 416
Runte, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.23.2687 · Cited by 391
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons
Huang, H.-S., Allen, J. A., Mabb, A. M., King, I. F., Miriyala, J., Taylor-Blake, B., Sciaky, N., Dutton, J. W., Lee, H.-M., Chen, X., et al. (2012) · Nature · doi:10.1038/nature10726 · Cited by 387
Flagged first, then by citations
Cited by
Sorted by citations
Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
Beermann, J., Piccoli, M.-T., Viereck, J., & Thum, T. (2016) · Physiological Reviews · doi:10.1152/physrev.00041.2015 · Cited by 1,740
Non-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,042
X-Inactivation, Imprinting, and Long Noncoding RNAs in Health and Disease
Lee, J. T., & Bartolomei, M. S. (2013) · Cell · doi:10.1016/j.cell.2013.02.016 · Cited by 674
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA
Meng, L., Ward, A. J., Chun, S. J., Bennett, C. F., Beaudet, A. L., & Rigo, F. (2014) · Nature · doi:10.1038/nature13975 · Cited by 537
Self-citationTopoisomerases facilitate transcription of long genes linked to autism
King, I. F. G., Yandava, C., Mabb, A. M., Hsiao, J. S., Huang, H., Pearson, B. L., Calabrese, J. M., Starmer, J., Parker, J. S., Magnuson, T., et al. (2013) · Nature · doi:10.1038/nature12504 · Cited by 430
The role of genomic imprinting in biology and disease: an expanding view
Peters, J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3766 · Cited by 432
Angelman syndrome — insights into a rare neurogenetic disorder
Buiting, K., Williams, C. A., & Horsthemke, B. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.133 · Cited by 414
From Discovery to Function: The Expanding Roles of Long NonCoding RNAs in Physiology and Disease
Sun, M., & Kraus, W. L. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1034 · Cited by 394
Epigenetics and Human DiseasePreprint
Zoghbi, H. Y., & Beaudet, A. L. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019497 · Cited by 371
Self-citationTranscription regulation by long non-coding RNAs: mechanisms and disease relevance
Ferrer, J. P., & Dimitrova, N. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00694-9 · Cited by 352
Long noncoding RNAs in development and disease of the central nervous system
Ng, S., Lin, L., Soh, B.-S., & Stanton, L. W. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.03.002 · Cited by 313
Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms
Tordjman, S., Somogyi, E., Coulon, N., Kermarrec, S., Cohen, D., Bronsard, G., Bonnot, O., Weismann-Arcache, C., Botbol, M., Lauth, B., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00053 · Cited by 283
Long non-coding RNA in health and disease
Maass, P. G., Luft, F. C., & Bähring, S. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1131-8 · Cited by 241
Angelman syndrome: review of clinical and molecular aspects
Bird, L. M. (2014) · The Application of Clinical Genetics · doi:10.2147/tacg.s57386 · Cited by 239
Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model
Silva-Santos, S., van Woerden, G. M., Bruinsma, C. F., Mientjes, E., Jolfaei, M. A., Distel, B., Kushner, S. A., & Elgersma, Y. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80554 · Cited by 238
lncRNAs: Insights into their function and mechanics in underlying disorders
Li, X., Wu, Z., Fu, X., & Han, W. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.04.002 · Cited by 233
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Out of Balance: R-loops in Human Disease
Groh, M., & Gromak, N. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004630 · Cited by 204
Long noncoding RNAs: Lessons from genomic imprinting
Kanduri, C. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.05.006 · Cited by 192
Kornienko, A. E., Dotter, C. P., Guenzl, P. M., Gisslinger, H., Gisslinger, B., Cleary, C., Královics, R., Pauler, F. M., & Barlow, D. P. (2016) · Genome biology · doi:10.1186/s13059-016-0873-8 · Cited by 172
Meng, L., Person, R., Huang, W., Zhu, P., Costa‐Mattioli, M., & Beaudet, A. L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1004039 · Cited by 165
Self-citationKim, Y., Lee, H.-M., Xiong, Y., Sciaky, N., Hulbert, S. W., Cao, X., Everitt, J. I., Jin, J. J., Roth, B. L., & Jiang, Y. (2016) · Nature Medicine · doi:10.1038/nm.4257 · Cited by 162
Powell, W. T., Coulson, R. L., Gonzales, M. L., Crary-Dooley, F. K., Wong, S. S., Adams, S., Ach, R. A., Tsang, P. W. K., Yamada, N. A., Yasui, D. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305426110 · Cited by 155
Knauss, J. L., & Sun, T. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.022 · Cited by 144
Allelic specificity of Ube3a Expression In The Mouse Brain During Postnatal Development
Judson, M. C., Sosa‐Pagan, J. O., Cid, W. A. D., Han, J. E., & Philpot, B. D. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23507 · Cited by 141
Long Non-Coding RNA (lncRNA) Roles in Cell Biology, Neurodevelopment and Neurological Disorders
Aliperti, V., Skonieczna, J., & Cerase, A. (2021) · Non-Coding RNA · doi:10.3390/ncrna7020036 · Cited by 137
Epigenetic Regulation of UBE3A and Roles in Human Neurodevelopmental Disorders
LaSalle, J. M., Reiter, L. T., & Chamberlain, S. J. (2015) · Epigenomics · doi:10.2217/epi.15.70 · Cited by 139
Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1.
Liu, C., & Lin, J. (2016) · PubMed Central · Cited by 127
Directed RNase H Cleavage of Nascent Transcripts Causes Transcription Termination
Lai, F., Damle, S. S., Ling, K., & Rigo, F. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.029 · Cited by 123
Epigenetics, Autism Spectrum, and Neurodevelopmental Disorders
Rangasamy, S., D’Mello, S. R., & Narayanan, V. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0227-0 · Cited by 121
Forging our understanding of lncRNAs in the brain
Andersen, R., & Lim, D. A. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2711-z · Cited by 114
Significance of epigenetics for understanding brain development, brain evolution and behaviour
Keverne, E. B. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.030 · Cited by 104
Mould, A. W., Pang, Z., Pakusch, M., Tonks, I. D., Stark, M. S., Carrie, D., Mukhopadhyay, P., Seidel, A., Ellis, J. J., Deakin, J. E., et al. (2013) · Epigenetics & Chromatin · doi:10.1186/1756-8935-6-19 · Cited by 100
Dindot, S. V., Christian, S., Murphy, W. J., Berent, A., Panagoulias, J., Schlafer, A., Ballard, J. L., Radeva, K., Robinson, R., Myers, L. S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abf4077 · Cited by 97
Epilepsy in Angelman syndrome: A scoping review
Samanta, D. (2020) · Brain and Development · doi:10.1016/j.braindev.2020.08.014 · Cited by 93
Milazzo, C., Mientjes, E., Wallaard, I., Rasmussen, S. V., Erichsen, K. D., Kakunuri, T., van der Sman, A. S. E., Kremer, T., Miller, M. T., Hoener, M. C., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.145991 · Cited by 94
Angelman Syndrome: From Mouse Models to Therapy
Rotaru, D. C., Mientjes, E., & Elgersma, Y. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.017 · Cited by 83
The role of long non-coding RNAs in the pathogenesis of hereditary diseases
Sparber, P. A., Filatova, A. Y., Khantemirova, M., & Skoblov, M. Y. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0487-6 · Cited by 81
Amanat, M., Nemeth, C. L., Fine, A. S., Leung, D. G., & Fatemi, A. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112389 · Cited by 78
Long non‐coding RNAs in corticogenesis: deciphering the non‐coding code of the brain
Aprea, J., & Calegari, F. (2015) · The EMBO Journal · doi:10.15252/embj.201592655 · Cited by 72
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
Turner, T. J., Zourray, C., Schorge, S., & Lignani, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15168 · Cited by 71
Mutation Update for UBE3A Variants in Angelman Syndrome
Sadiković, B., Fernandes, P. H., Zhang, V. W., Ward, P. A., Miloslavskaya, I., Rhead, W. J., Rosenbaum, R., Gin, R., Roa, B. B., & Fang, P. (2014) · Human Mutation · doi:10.1002/humu.22687 · Cited by 70
Long noncoding RNA functionality in imprinted domain regulation
MacDonald, W. A., & Mann, M. R. W. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008930 · Cited by 70
Epilepsy and Cognitive Impairment in Childhood and Adolescence: A Mini-Review
Operto, F. F., Pastorino, G. M. G., Viggiano, A., Dell’Isola, G. B., Dini, G., Verrotti, A., & Coppola, G. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220706102708 · Cited by 76
Global assessment of imprinted gene expression in the bovine conceptus by next generation sequencing
Chen, Z., Hagen, D. E., Wang, J., Elsik, C. G., Ji, T., Siqueira, L. G. B., Hansen, P. J., & Rivera, R. M. (2016) · Epigenetics · doi:10.1080/15592294.2016.1184805 · Cited by 69
Long noncoding RNA and its contribution to autism spectrum disorders
Tang, J., Yu, Y., & Yang, W. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12710 · Cited by 67
Martins-Taylor, K., Hsiao, J. S., Chen, P.-F., Glatt-Deeley, H., De Smith, A. J., Blakemore, A. I. F., Lalande, M., & Chamberlain, S. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt628 · Cited by 66
Tordjman, S., Cohen, D., Anderson, G. M., Botbol, M., Canitano, R., Coulon, N., & Roubertoux, P. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.014 · Cited by 70
Natural antisense transcripts in diseases: From modes of action to targeted therapies
Wanowska, E., Kubiak, M. R., Rosikiewicz, W., Makałowska, I., & Szcześniak, M. W. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1461 · Cited by 65
CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review
Syding, L. A., Nickl, P., Kašpárek, P., & Sedláček, R. (2020) · Cells · doi:10.3390/cells9040993 · Cited by 65
From Junk to Function: LncRNAs in CNS Health and Disease
Policarpo, R., Sierksma, A. S. R., Strooper, B. D., & d’Ydewalle, C. V. O. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.714768 · Cited by 63
Andergassen, D., Muckenhuber, M., Bammer, P. C., Kuliński, T. M., Theussl, H., Shimizu, T., Penninger, J. M., Pauler, F. M., & Hudson, Q. J. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008268 · Cited by 55
RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases
Germain, N. D., Chung, W. K., & Sarmiere, P. D. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101148 · Cited by 59
UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
Elgersma, Y., & Sonzogni, M. (2021) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14831 · Cited by 60
Differential regulation of non-protein coding RNAs from Prader-Willi Syndrome locus
Galiveti, C. R., Raabe, C. A., Konthur, Z., & Rozhdestvensky, T. S. (2014) · Scientific Reports · doi:10.1038/srep06445 · Cited by 53
Epigenetic therapy of Prader–Willi syndrome
Kim, Y., Wang, S. E., & Jiang, Y. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.012 · Cited by 53
Epigenetic mechanisms in epilepsy
Kobow, K., & Blümcke, I. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00014-4 · Cited by 57
Contribution of Long Noncoding RNAs to Autism Spectrum Disorder Risk
Wilkinson, B., & Campbell, D. B. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-418700-9.00002-2 · Cited by 48
The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives
Casallas, J. C. G., & Bustos, R. (2018) · Brain Sciences · doi:10.3390/brainsci8120222 · Cited by 49
Therapies in preclinical and clinical development for Angelman syndrome
Markati, T., Duis, J. B., & Servais, L. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1939674 · Cited by 49
Hipp, J. F., Bacino, C. A., Bird, L. M., Bruenig-Traebert, I., Chan, D., de Wit, M. Y., da Fontoura, P. P., Hooper, G., Jagasia, R., Krishnan, M. L., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03784-7 · Cited by 47
Sonzogni, M., Zhai, P., Mientjes, E., van Woerden, G. M., & Elgersma, Y. (2020) · Molecular Autism · doi:10.1186/s13229-020-00376-9 · Cited by 42
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome
Copping, N. A., McTighe, S. M., Fink, K. D., & Silverman, J. L. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01082-x · Cited by 42
Langouët, M., Glatt-Deeley, H. R., Chung, M. S., Dupont-Thibert, C. M., Mathieux, E., Banda, E. C., Stoddard, C. E., Crandall, L. J., & Lalande, M. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx420 · Cited by 39
Li, J., Shen, Z., Liu, Y., Yan, Z., Liu, Y., Lin, X., Tang, J., Lv, R., Geng, G., Xiong, Z., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.015 · Cited by 40
Liu, H., Shang, X., & Zhu, H. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw818 · Cited by 38
Non-coding Natural Antisense Transcripts: Analysis and Application
Krappinger, J. C., Bonstingl, L., Pansy, K., Sallinger, K., Wreglesworth, N. I., Grinninger, L., Deutsch, A. J. A., Heliebi, A. E., Kroneis, T., McFarlane, R. J., et al. (2021) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2021.08.005 · Cited by 38
The Role of Non-Coding RNAs in Neurodevelopmental Disorders
Zhang, S.-F., Gao, J., & Liu, C. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01033 · Cited by 41
Epigenetic mechanisms in diurnal cycles of metabolism and neurodevelopment
Powell, W. T., & LaSalle, J. M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv234 · Cited by 36
Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion
Dodge, A., Peters, M. M., Greene, H. E., Dietrick, C., Botelho, R., Chung, D., Willman, J., Nenninger, A. W., Ciarlone, S. L., Kamath, S. G., et al. (2020) · Autism Research · doi:10.1002/aur.2267 · Cited by 36
Robert, C., Pasquier, L., Cohen, D., Fradin, M., Canitano, R., Damaj, L., Odent, S., & Tordjman, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030618 · Cited by 37
RNAs of the human chromosome 15q11-q13 imprinted region
Chamberlain, S. J. (2013) · WIREs RNA · doi:10.1002/wrna.1150 · Cited by 35
Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice
Jones, K. A., Han, J. E., DeBruyne, J. P., & Philpot, B. D. (2016) · Scientific Reports · doi:10.1038/srep28238 · Cited by 34
Effect of the autism‐associated lncRNA Shank2‐AS on architecture and growth of neurons
Luo, T., Liu, P., Wang, X., Li, L., Zhao, L., Huang, J., Li, Y., Ou, J., & Peng, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27471 · Cited by 36
Dosage-sensitive genes in autism spectrum disorders: From neurobiology to therapy
Javed, S., Selliah, T., Lee, Y., & Huang, W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.009 · Cited by 31
Lee, D., Chen, W., Kaku, H. N., Zhuo, X., Chao, E. S., Soriano, A., Kuncheria, A., Flores, S., Kim, J. H., Rivera, A. M., et al. (2023) · eLife · doi:10.7554/elife.81892 · Cited by 36
Self-citationUbe3a unsilencer for the potential treatment of Angelman syndrome
Vihma, H., Li, K., Welton-Arndt, A., Smith, A. L., Bettadapur, K. R., Gilmore, R. B., Gao, E. B., Cotney, J. L., Huang, H.-C., Collins, J. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49788-8 · Cited by 33
Human Cerebral Organoids Reveal Early Spatiotemporal Dynamics and Pharmacological Responses of UBE3A
Sen, D., Voulgaropoulos, A., Drobná, Z., & Keung, A. J. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.08.006 · Cited by 32
The Role of Long Non-coding RNAs in Human Imprinting Disorders: Prospective Therapeutic Targets
Wang, T., Li, J. J., Yang, L., Wu, M., & Ma, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.730014 · Cited by 33
Grier, M. D., Carson, R. P., & Lagrange, A. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124649 · Cited by 29
Vickers, R. R., & Gibson, J. S. (2019) · Cureus · doi:10.7759/cureus.3873 · Cited by 30
Born, H. A., Martinez, L. A., Levine, A. T., Harris, S. E., Mehra, S., Lee, W. L., Dindot, S. V., Nash, K. R., Silverman, J. L., Segal, D. J., et al. (2021) · eNeuro · doi:10.1523/eneuro.0345-20.2020 · Cited by 28
The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders
Bailus, B. J., & Segal, D. J. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-76 · Cited by 28
Functional genomics of human brain development and implications for autism spectrum disorders
Ziats, M. N., Grosvenor, L. P., & Rennert, O. M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.153 · Cited by 27
Age-Related Expression of a Repeat-Rich Intergenic Long Noncoding RNA in the Rat Brain
Kour, S., & Rath, P. C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9634-z · Cited by 27
Novel epigenetic molecular therapies for imprinting disorders
Wang, S. E., & Jiang, Y. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02208-7 · Cited by 26
Coulson, R. L., Powell, W. T., Yasui, D. H., Dileep, G., Resnick, J. L., & LaSalle, J. M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy296 · Cited by 25
Potential therapeutic approaches for Angelman syndrome
Bi, X., Sun, J., Ji, A. X., & Baudry, M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1115837 · Cited by 27
Prenatal treatment path for angelman syndrome and other neurodevelopmental disorders
Zylka, M. J. (2019) · Autism Research · doi:10.1002/aur.2203 · Cited by 24
E6AP in the Brain: One Protein, Dual Function, Multiple Diseases
Hokayem, J. A. E., & Nawaz, Z. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8563-y · Cited by 25
Chromatinopathies: insight in clinical aspects and underlying epigenetic changes
Bukowska‐Olech, E., Majchrzak‐Celińska, A., Przyborska, M., & Jamsheer, A. (2024) · Journal of Applied Genetics · doi:10.1007/s13353-023-00824-1 · Cited by 23
Being in a loop: how long non-coding RNAs organise genome architecture
Pisignano, G., Pavlaki, I., & Murrell, A. (2019) · Essays in Biochemistry · doi:10.1042/ebc20180057 · Cited by 21
Ben‐David, E., Shohat, S., & Shifman, S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu128 · Cited by 21
Offensperger, F., Müller, F., Jansen, J., Hammler, D., Götz, K., Marx, A., Sirois, C. L., Chamberlain, S. J., Stengel, F., & Scheffner, M. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.08.017 · Cited by 21
Ambrozkiewicz, M. C., Cuthill, K. J., Harnett, D., Kawabe, H., & Tarabykin, V. S. (2020) · Cells · doi:10.3390/cells9112455 · Cited by 21
Behavioral Evaluation of Angelman Syndrome Mice at Older Ages
Dutta, R., & Crawley, J. N. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.027 · Cited by 22
lncRNA expression in the auditory forebrain during postnatal development
Guo, Y. P., Zhang, P., Sheng, Q., Zhao, S., & Hackett, T. A. (2016) · Gene · doi:10.1016/j.gene.2016.08.027 · Cited by 20
Angelman syndrome and melatonin: What can they teach us about sleep regulation
Buonfiglio, D. D. C., Hummer, D. L., Armstrong, A., Ehlen, J. C., & DeBruyne, J. P. (2020) · Journal of Pineal Research · doi:10.1111/jpi.12697 · Cited by 21
A mouse model of Angelman syndrome imprinting defects
Lewis, M. W., Vargas‐Franco, D., Morse, D. A., & Resnick, J. L. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy345 · Cited by 19
Langouët, M., Gorka, D., Orniacki, C., Dupont-Thibert, C. M., Chung, M. S., Glatt-Deeley, H. R., Germain, N. D., Crandall, L. J., Cotney, J. L., Stoddard, C. E., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa210 · Cited by 19
Metadata
- Authors
- Meng, L., Person, R. E., & Beaudet, A. L.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Beaudet, Arthur L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-04-05
- Volume
- 21
- Issue
- 13
- Pages
- 3001-3012
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC3465693
- OpenAlex
- W2155623567
- Cited by
- 202
- References
- 48
- Citations by year
- 2026: 16 · 2025: 10 · 2024: 17 · 2023: 11 · 2022: 13 · 2021: 11 · 2020: 22 · 2019: 13 · 2018: 8 · 2017: 7 · 2016: 16 · 2015: 16 · 2014: 23 · 2013: 15 · 2012: 4
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Intellectual and Developmental Disabilities Research Center
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD037283)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- UBE3A, genomic imprinting, antisense RNA, RNA polymerase II, paternal gene expression, Angelman syndrome, Prader-Willi syndrome, RNA stability, transcription termination, embryonic stem cells, treatment options
- MeSH terms
- Animals, Cells, Cultured, Female, Humans, Male, Mice, Inbred C57BL, Neurons, Promoter Regions, Genetic, RNA Polymerase II, Transcription, Genetic, RNA, Antisense, Angelman Syndrome, Genomic Imprinting, Polyadenylation, Ubiquitin-Protein Ligases, Mice, Embryonic Stem Cells, snRNP Core Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
